🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks to Jon Campbell for presenting at our departmental seminar today on the research happening at NPC.

During my residency, Alliance for Health Policy opened my eyes to the importance of good evidence — so I’m excited to participate in their Post-Election Symposium today! Join me, Adam B. Colborn AMCP, Rachel Nuzum Commonwealth Fund, & Dr. Marc Samuels ADVI: allhealthpolicy.org/events/panel-2…

What are the challenges that patients & caregivers face in accessing cell & gene therapy (#CGT)? Our latest white paper explores the roadblocks that need to be addressed to improve outcomes & access for people with complex or rare conditions. npcnow.org/sites/default/…

Honored to see our research on this important topic in the pages of Health Affairs Forefront. healthaffairs.org/content/forefr…

Learn 4 reasons why comparing a launch price with a value-based price from a conventional cost-effectiveness analysis requires further examination in our newest AJMC commentary:

John O'Brien, President and CEO of National Pharmaceutical Council (NPC), joined The Hill at the Health Next Summit. He discussed priorities for the year ahead, unintended consequences of the Inflation Reduction Act (IRA), and what makes PBM reform so important. Watch The

Per President & CEO of NPC, meaningful reform of #PBMs and the #340B Hospital Markup Program would help curb health care costs for patients. #PBMReform #340BReform ajmc.com/view/trump-adm…

Implementing the patient perspective into payer decisions requires intentional systems & processes. A new commentary in Health Affairs Forefront summarizes lessons from patient advocacy, patient-centered research, & value assessment initiatives. healthaffairs.org/content/forefr…

At #ASCO2025, NPC presented research on early signals of the impact of the #IRA in oncology. Watch the video below to hear more about the findings directly from Research Manager Hanke Zheng! For more, view the full poster here: lnkd.in/ejeuHyCD

In their new Forefront article, Kimberly Westrich, Lisabeth Buelt, James Motyka, and Jon Campbell from NPC argue that efforts to reform utilization management policies must prioritize clinical value, improve transparency, ensure alignment with evidence-based guidelines, and

Our new primer, published today in Health Affairs, recounts the evolution of medication utilization management strategies over time, how they affect patient care, and the broader implications for future healthcare policy. Read the report below.